MyFinsight
Home
Blog
About
Fixed deposits placed
with financial...
$2,288,874
(1.97%↑ Y/Y)
Cash and bank
balances
$1,232,658
(51.40%↑ Y/Y)
Inventories
$652,892
(-46.29%↓ Y/Y)
Other assets
$583,331
Other receivables,
deposits and prepayments
$108,975
(-27.96%↓ Y/Y)
Tax recoverable
$61,135
(-39.75%↓ Y/Y)
Trade receivables,
net of allowance for...
$15,544
(-99.16%↓ Y/Y)
Investments in equity
securities
$2,026,543
(62.29%↑ Y/Y)
Property, plant and
equipment, net
$1,537,800
(-3.46%↓ Y/Y)
Operating lease
right-of-use assets
$146,542
(-26.83%↓ Y/Y)
Finance lease
right-of-use assets
$72,129
Total current assets
$4,943,409
(-22.51%↓ Y/Y)
Total non-current
assets
$3,783,014
(24.36%↑ Y/Y)
Total assets
$8,726,423
(-7.37%↓ Y/Y)
Total liabilities and
stockholders' equity
$8,726,423
(-7.37%↓ Y/Y)
Total stockholders'
equity
$7,778,442
(3.41%↑ Y/Y)
Total liabilities
$947,981
(-50.08%↓ Y/Y)
Accumulated deficit
-$7,257,253
(-55.00%↓ Y/Y)
Additional paid in capital
-$5,011,891
(0.00%↑ Y/Y)
Accumulated other
comprehensive losses
-$127,209
(-9.89%↓ Y/Y)
As at june 30, 2026,
common stock, no par...
$20,174,795
(16.40%↑ Y/Y)
Total current
liabilities
$812,938
(-53.75%↓ Y/Y)
Total non-current
liabilities
$135,043
(-4.46%↓ Y/Y)
Other payables and
accrued liabilities...
$608,537
Amount owing to
directors
$124,612
(689.23%↑ Y/Y)
Operating lease
liabilities
$56,677
(1.56%↑ Y/Y)
Advance payment from
customer
$8,351
(-26.41%↓ Y/Y)
Trade payables
$7,896
(-99.42%↓ Y/Y)
Finance lease
liabilities
$6,865
Operating lease
liabilities
$89,350
(-36.79%↓ Y/Y)
Finance lease
liabilities
$45,693
Back
Back
Balance Sheet
BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp (BGLC)
source: myfinsight.com